The current stock price of PRFX is 0.95 USD. In the past month the price increased by 6.28%. In the past year, price decreased by -66.88%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 46.35 | 963.49B | ||
| JNJ | JOHNSON & JOHNSON | 20.29 | 507.30B | ||
| MRK | MERCK & CO. INC. | 11.31 | 247.21B | ||
| PFE | PFIZER INC | 8.06 | 146.58B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.01 | 106.91B | ||
| ZTS | ZOETIS INC | 18.79 | 52.49B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.29 | 22.04B | ||
| VTRS | VIATRIS INC | 4.99 | 13.39B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22 | 10.49B | ||
| CORT | CORCEPT THERAPEUTICS INC | 99.02 | 9.17B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.33B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 4.98B |
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
PAINREFORM LTD
65 Yigal Alon St.
TEL AVIV-YAFO 6745442 IL
CEO: Ilan Hadar
Employees: 2
Phone: 97237177051
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
The current stock price of PRFX is 0.95 USD. The price decreased by -7.77% in the last trading session.
PRFX does not pay a dividend.
PRFX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
PRFX stock is listed on the Nasdaq exchange.
PAINREFORM LTD (PRFX) has a market capitalization of 3.72M USD. This makes PRFX a Nano Cap stock.
You can find the ownership structure of PAINREFORM LTD (PRFX) on the Ownership tab.
ChartMill assigns a technical rating of 1 / 10 to PRFX. When comparing the yearly performance of all stocks, PRFX is a bad performer in the overall market: 95.04% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to PRFX. PRFX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months PRFX reported a non-GAAP Earnings per Share(EPS) of -32.16. The EPS increased by 81.23% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -130.69% | ||
| ROE | -172.78% | ||
| Debt/Equity | 0 |